STOCK TITAN

Director at Bausch & Lomb (BLCO) receives 1,451 restricted share units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bausch & Lomb Corp director Russel C. Robertson acquired 1,451 restricted share units on common shares through a grant. The award was valued at $17.65 per share and increased his directly held position to 68,007 common shares, aligning his compensation partly with shareholder value.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ROBERTSON RUSSEL C

(Last) (First) (Middle)
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT

(Street)
VAUGHAN A6 L4K 4B4

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, No Par Value 02/19/2026 A 1,451(1) A $17.65 68,007 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.
/s/ Debra E. Levin, attorney-in-fact 02/23/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BLCO director Russel C. Robertson report on this Form 4?

Director Russel C. Robertson reported receiving 1,451 restricted share units of Bausch & Lomb common shares as a grant. Each unit represents a contingent right to one common share, increasing his directly held position to 68,007 shares after the award.

Was the BLCO Form 4 transaction a stock purchase or an equity award?

The BLCO Form 4 shows an equity award, not an open-market purchase. Russel C. Robertson acquired 1,451 restricted share units as a grant, classified as a “grant, award, or other acquisition” rather than a buy transaction at a market or negotiated price.

How many Bausch & Lomb shares does Russel C. Robertson hold after this Form 4 grant?

Following the reported grant, Russel C. Robertson directly holds 68,007 Bausch & Lomb common shares. This total includes the newly awarded 1,451 restricted share units, each representing a contingent right to receive one common share of the company.

What is the value per share used for the BLCO restricted share unit grant?

The grant to Russel C. Robertson used a value of $17.65 per common share. This figure applies to each of the 1,451 restricted share units reported, providing a reference amount for the award’s size in the Form 4 disclosure.

What do the BLCO restricted share units reported in the Form 4 represent?

The restricted share units reported for BLCO each represent a contingent right to receive one common share of Bausch & Lomb. These units typically vest over time or upon conditions, aligning director compensation with future company performance and share value.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

6.37B
38.57M
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN